Literature DB >> 19377506

Targeting DNA topoisomerase II in cancer chemotherapy.

John L Nitiss1.   

Abstract

Recent molecular studies have expanded the biological contexts in which topoisomerase II (TOP2) has crucial functions, including DNA replication, transcription and chromosome segregation. Although the biological functions of TOP2 are important for ensuring genomic integrity, the ability to interfere with TOP2 and generate enzyme-mediated DNA damage is an effective strategy for cancer chemotherapy. The molecular tools that have allowed an understanding of the biological functions of TOP2 are also being applied to understanding the details of drug action. These studies promise refined targeting of TOP2 as an effective anticancer strategy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377506      PMCID: PMC2748742          DOI: 10.1038/nrc2607

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  164 in total

1.  Type II DNA topoisomerase from Saccharomyces cerevisiae is a stable dimer.

Authors:  R B Tennyson; J E Lindsley
Journal:  Biochemistry       Date:  1997-05-20       Impact factor: 3.162

2.  Multiple endonucleases function to repair covalent topoisomerase I complexes in Saccharomyces cerevisiae.

Authors:  Changchun Deng; James A Brown; Dongqing You; J Martin Brown
Journal:  Genetics       Date:  2005-04-16       Impact factor: 4.562

Review 3.  Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.

Authors:  D Roulston; J Anastasi; R Rudinsky; G Nucifora; N Zeleznik-Le; J D Rowley; L McGavran; M Tsuchida; Y Hayashi
Journal:  Blood       Date:  1995-11-01       Impact factor: 22.113

4.  Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase I on chromosome 20.

Authors:  W N Keith; F Douglas; G C Wishart; H M McCallum; W D George; S B Kaye; R Brown
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

Review 5.  DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide.

Authors:  P B Jensen; M Sehested
Journal:  Biochem Pharmacol       Date:  1997-10-01       Impact factor: 5.858

6.  Covalent protein-DNA complexes at the 5' strand termini of meiosis-specific double-strand breaks in yeast.

Authors:  S Keeney; N Kleckner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses.

Authors:  Jia-Rong Fan; An-Lin Peng; Hsiang-Chin Chen; Shu-Chi Lo; Ting-Hsiang Huang; Tsai-Kun Li
Journal:  DNA Repair (Amst)       Date:  2008-03-01

8.  Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancer.

Authors:  Shannon Puhalla; Ewa Mrozek; Donn Young; Susan Ottman; Anne McVey; Kari Kendra; Nancy J Merriman; Mark Knapp; Taral Patel; Mark E Thompson; James F Maher; Timothy D Moore; Charles L Shapiro
Journal:  J Clin Oncol       Date:  2008-03-03       Impact factor: 44.544

9.  Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase.

Authors:  M Cotten; D Bresnahan; S Thompson; L Sealy; R Chalkley
Journal:  Nucleic Acids Res       Date:  1986-05-12       Impact factor: 16.971

10.  Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.

Authors:  Yan Zhao; Huw D Thomas; Michael A Batey; Ian G Cowell; Caroline J Richardson; Roger J Griffin; A Hilary Calvert; David R Newell; Graeme C M Smith; Nicola J Curtin
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

View more
  563 in total

1.  Mammalian Fbh1 is important to restore normal mitotic progression following decatenation stress.

Authors:  Corentin Laulier; Anita Cheng; Nick Huang; Jeremy M Stark
Journal:  DNA Repair (Amst)       Date:  2010-04-24

Review 2.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

3.  Relationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposide.

Authors:  Hong Zhao; Paulina Rybak; Jurek Dobrucki; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2011-12-02       Impact factor: 4.355

4.  Nucleolar disruption and apoptosis are distinct neuronal responses to etoposide-induced DNA damage.

Authors:  Maciej Pietrzak; Scott C Smith; Justin T Geralds; Theo Hagg; Cynthia Gomes; Michal Hetman
Journal:  J Neurochem       Date:  2011-05-13       Impact factor: 5.372

5.  Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.

Authors:  Junko Murai; Shar-yin N Huang; Benu Brata Das; Thomas S Dexheimer; Shunichi Takeda; Yves Pommier
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

6.  Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach.

Authors:  Chen Fang; Forrest M Kievit; Omid Veiseh; Zachary R Stephen; Tingzhong Wang; Donghoon Lee; Richard G Ellenbogen; Miqin Zhang
Journal:  J Control Release       Date:  2012-06-24       Impact factor: 9.776

7.  Type IIA topoisomerase inhibition by a new class of antibacterial agents.

Authors:  Benjamin D Bax; Pan F Chan; Drake S Eggleston; Andrew Fosberry; Daniel R Gentry; Fabrice Gorrec; Ilaria Giordano; Michael M Hann; Alan Hennessy; Martin Hibbs; Jianzhong Huang; Emma Jones; Jo Jones; Kristin Koretke Brown; Ceri J Lewis; Earl W May; Martin R Saunders; Onkar Singh; Claus E Spitzfaden; Carol Shen; Anthony Shillings; Andrew J Theobald; Alexandre Wohlkonig; Neil D Pearson; Michael N Gwynn
Journal:  Nature       Date:  2010-08-04       Impact factor: 49.962

8.  Direct and Topoisomerase II Mediated DNA Damage by Bis-3-chloropiperidines: The Importance of Being an Earnest G.

Authors:  Alice Sosic; Ivonne Zuravka; Nina-Katharina Schmitt; Angelica Miola; Richard Göttlich; Dan Fabris; Barbara Gatto
Journal:  ChemMedChem       Date:  2017-08-10       Impact factor: 3.466

Review 9.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

10.  Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide.

Authors:  Luke Pett; Konstantinos Kiakos; Vijay Satam; Pravin Patil; Sarah Laughlin-Toth; Matthew Gregory; Michael Bowerman; Kevin Olson; Mia Savagian; Megan Lee; Moses Lee; W David Wilson; Daniel Hochhauser; John A Hartley
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2016-10-24       Impact factor: 4.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.